Skip to Main Content

Lab session (circle or highlight your lab section): Monday, Wednesday

Classification of article

Summary of clinical studies

| Download (.pdf) | Print
Medication:
Student’s Name Title of the Article Author, Year Class
      I, II, III, IV
      I, II, III, IV
      I, II, III, IV
      I, II, III, IV

| Download (.pdf) | Print
Medication:
Student’s Name Title of the Article Author, Year Class
      I, II, III, IV
      I, II, III, IV
      I, II, III, IV
      I, II, III, IV

See the following information resource for additional guidance:

+
Gronseth  G, Cox  J, Gloss  D,  et al. Clinical practice guideline process manual. In: American Academy of Neurology, ed. 2017 ed. St. Paul, MN: American Academy of Neurology; 2017. https://www.aan.com/siteassets/home-page/policy-and-guidelines/guidelines/about-guidelines/17guidelineprocman_pg.pdf

Level of evidence analysis

| Download (.pdf) | Print
Level of evidence* of (insert drug name here)
Check Level Determination
  Level A

Number of Class I study:

Number of Class II study:

Number of Class III study:

Number of Class IV study:

Conclusion:

  Level B
  Level C
  Level U

| Download (.pdf) | Print
Level of evidence* of (insert drug name here)
Check Level Determination
  Level A

Number of Class I study:

Number of Class II study:

Number of Class III study:

Number of Class IV study:

Conclusion:

  Level B
  Level C
  Level U

See the following information resource for additional guidance:

+
Miyasaki  JM, Martin  W, Suchowersky  O, Weiner  WJ, Lang  AE. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2002;58(1):11–17.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.